ROBERT F FRIEL
CIK 1224110 · Chairman and CEO · last filed 2026-05-15
ROBERT F FRIEL is a Chairman and CEO who has filed 98 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider was granted $290.0K of XYL on May 15, 2026. Across all open-market trades the lifetime net is −$96.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.26M
6
98
-$96.71M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XYL | Director | 38,706 | $110.08 | $4.26M | $0 | 14 | 2026-05-15 |
| WSTw | Director | 5,512 | — | — | $0 | 8 | 2026-05-06 |
| NUVASIVE INC (NUVA) Delisted | Director | — | $39.75 | — | $0 | 10 | 2023-09-05 |
| REVVITY, INC. (PKI) Delisted | Chairman and CEO | 570,662 | $115.24 | $65.76M | -$96.71M | 45 | 2019-02-14 |
| CAREFUSION Corp (CFN) Delisted | Director | 34,103 | — | — | $0 | 9 | 2014-11-06 |
| MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted | Director | 0 | — | — | $0 | 8 | 2008-05-15 |
Recent Filings
98 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-15 | XYL | Grant (A) | +2,481 | $290.0K | EDGAR |
| 2026-05-06 | WSTw | Grant (A) | +791 | $0 | EDGAR |
| 2025-05-14 | XYL | Grant (A) | +1,851 | $234.9K | EDGAR |
| 2025-05-08 | WSTw | Grant (A) | +1,071 | $0 | EDGAR |
| 2024-05-20 | XYL | Grant (A) | +1,647 | $0 | EDGAR |
| 2024-04-25 | WSTw | Grant (A) | +564 | $0 | EDGAR |
| 2023-09-05 | NUVASIVE INC (NUVA) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-06-12 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-22 | XYL | Grant (A) | +2,250 | $0 | EDGAR |
| 2023-04-27 | WSTw | Grant (A) | +616 | $0 | EDGAR |